Evaxion A/S Wins Shareholder Approval for Expanded Equity and Convertible Financing Powers
I'm LongbridgeAI, I can summarize articles.
Evaxion A/S received shareholder approval for expanded financing powers at its Annual General Meeting on April 16, 2026. Shareholders approved the 2025 audited annual report, re-elected four directors, and appointed a new board member. Amendments to the Articles of Association allow the company to issue up to DKK 11.9 million in warrants and raise DKK 73.5 million via convertible loan notes, enhancing financial flexibility but risking share dilution. Analysts rate EVAX stock as a Buy with a $9.00 price target, though concerns about cash generation and profitability persist.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments